REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Statements For The Year Ended 31 August 2021 |
|
for |
|
Calder Pharmacy Limited |
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Statements For The Year Ended 31 August 2021 |
|
for |
|
Calder Pharmacy Limited |
Calder Pharmacy Limited (Registered number: SC268645) |
|
|
|
|
|
|
Contents of the Financial Statements |
For The Year Ended 31 August 2021 |
|
|
|
|
Page |
|
Company Information | 1 |
|
Abridged Statement of Financial Position | 2 |
|
Notes to the Financial Statements | 4 |
|
Calder Pharmacy Limited |
|
Company Information |
For The Year Ended 31 August 2021 |
|
|
|
|
|
|
|
DIRECTOR: |
|
|
|
|
|
|
SECRETARY: |
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
ACCOUNTANTS: |
|
Regent Court |
70 West Regent Street |
Glasgow |
G2 2QZ |
Calder Pharmacy Limited (Registered number: SC268645) |
|
Abridged Statement of Financial Position |
31 August 2021 |
|
2021 | 2020 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Intangible assets | 4 |
|
|
Tangible assets | 5 |
|
|
Investments | 6 |
|
|
Investment property | 7 |
|
|
|
|
|
CURRENT ASSETS |
Stocks |
|
|
Debtors |
|
|
Cash at bank |
|
|
|
|
CREDITORS |
Amounts falling due within one year |
|
|
NET CURRENT ASSETS |
|
|
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
CREDITORS |
Amounts falling due after more than one year | 8 | ( |
) | ( |
) |
|
PROVISIONS FOR LIABILITIES | ( |
) | ( |
) |
NET ASSETS |
|
|
|
CAPITAL AND RESERVES |
Called up share capital |
|
|
Fair value reserve | 10 |
|
|
Retained earnings |
|
|
|
|
|
|
|
|
|
The director acknowledges his responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
Calder Pharmacy Limited (Registered number: SC268645) |
|
Abridged Statement of Financial Position - continued |
31 August 2021 |
|
|
|
|
|
|
In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered. |
|
The financial statements were approved by the director and authorised for issue on
|
|
|
|
|
|
|
|
Calder Pharmacy Limited (Registered number: SC268645) |
|
Notes to the Financial Statements |
For The Year Ended 31 August 2021 |
|
1. | STATUTORY INFORMATION |
|
Calder Pharmacy Limited is a
|
|
The presentation currency of the financial statements is the Pound Sterling (£). |
|
|
2. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
|
|
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
|
Goodwill |
|
|
It is the directors view that a useful life of twenty years is appropriate given the enduring nature of goodwill within retail pharmacy businesses. |
|
Intangible assets |
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. |
|
Tangible fixed assets |
|
Fixtures and fittings | - |
|
Motor vehicles | - |
|
|
Investment property |
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value a t the reporting end date. Changes in fair value are recognised in |
profit or loss. |
|
Stocks |
Stocks are stated at the lower of cost and net realisable value after making due allowance for obsolete and |
slow moving items. Cost is determined on a first-in. first-out basis. Net realisable value is based on estimated selling price, less any further costs of realisation. |
|
Financial instruments |
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss. |
|
Calder Pharmacy Limited (Registered number: SC268645) |
|
Notes to the Financial Statements - continued |
For The Year Ended 31 August 2021 |
|
2. | ACCOUNTING POLICIES - continued |
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
|
Current or deferred taxation assets and liabilities are not discounted. |
|
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date. |
|
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
|
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
|
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
|
Hire purchase and leasing commitments |
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
|
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
|
Employee benefits |
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets. |
|
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received. |
|
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits. |
|
Government grants |
Government grants are recognised at the fair value of the asset receive d or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. |
|
3. | EMPLOYEES AND DIRECTORS |
|
The average number of employees during the year was
|
Calder Pharmacy Limited (Registered number: SC268645) |
|
Notes to the Financial Statements - continued |
For The Year Ended 31 August 2021 |
|
4. | INTANGIBLE FIXED ASSETS |
Totals |
£ |
COST |
At 1 September 2020 |
and 31 August 2021 |
|
AMORTISATION |
At 1 September 2020 |
|
Amortisation for year |
|
At 31 August 2021 |
|
NET BOOK VALUE |
|
At 31 August 2021 |
|
At 31 August 2020 |
|
|
5. | TANGIBLE FIXED ASSETS |
Totals |
£ |
COST |
At 1 September 2020 |
and 31 August 2021 |
|
DEPRECIATION |
At 1 September 2020 |
|
Charge for year |
|
At 31 August 2021 |
|
NET BOOK VALUE |
At 31 August 2021 |
|
At 31 August 2020 |
|
Calder Pharmacy Limited (Registered number: SC268645) |
|
Notes to the Financial Statements - continued |
For The Year Ended 31 August 2021 |
|
6. | FIXED ASSET INVESTMENTS |
|
Information on investments other than loans is as follows: |
Totals |
£ |
COST |
At 1 September 2020 | 31,296 |
Additions | 12,457 |
Impairments | (500 | ) |
At 31 August 2021 | 43,253 |
NET BOOK VALUE |
At 31 August 2021 | 43,253 |
At 31 August 2020 | 31,296 |
|
7. | INVESTMENT PROPERTY |
Total |
£ |
FAIR VALUE |
At 1 September 2020 |
and 31 August 2021 |
|
NET BOOK VALUE |
At 31 August 2021 |
|
At 31 August 2020 |
|
|
Investment property comprises three properties held to earn rental income. |
|
8. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE YEARS |
2021 | 2020 |
£ | £ |
Repayable by instalments |
Bank loans more than 5 years by instalments | 54,730 | 83,282 |
|
9. | SECURED DEBTS |
|
The following secured debts are included within creditors: |
|
2021 | 2020 |
£ | £ |
Bank loans |
|
|
|
The Royal Bank of Scotland PLC has a bond and floating charge over the undertaking and all property and |
assets present and future. |
|
The Royal Bank of Scotland PLC holds a fixed charge over the property at Leyland Road and another over |
the property at Sighthill Park. |
Calder Pharmacy Limited (Registered number: SC268645) |
|
Notes to the Financial Statements - continued |
For The Year Ended 31 August 2021 |
|
10. | RESERVES |
Fair |
value |
reserve |
£ |
At 1 September 2020 |
and 31 August 2021 |
|
|
11. | RELATED PARTY DISCLOSURES |
|
Included in other debtors is a balance of £85,503 (2020: £98,420) owed by Mr C Shanks, director of the company. Interest is charged at 2.5%. |